ATPW
ATRC icon

Ashton Thomas Private Wealth’s AtriCure ATRC Stock Holding History

Ashton Thomas Private Wealth’s Portfolio ATRC Stock Details ATRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-188
Closed -$4.28K – 703
2024
Q2 		$4.28K Buy
+188
New +$4.34K ﹤0.01% 1601

Other funds holding ATRC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return

Ashton Thomas Private Wealth's ATRC Position: Q3 2024 in Review

Ashton Thomas Private Wealth sold out of AtriCure (ATRC) in Q3 2024, closing a stake of 188 shares — an estimated $4.28K sold.

Ashton Thomas Private Wealth first reported a position in ATRC in Q2 2024 and held it in 1 quarter. The position peaked at $4.28K in Q2 2024. 201 funds tracked by Wall St. Rank hold ATRC as of Q3 2024.

  • Ashton Thomas Private Wealth reported no remaining AtriCure position as of Q3 2024 after selling out during the quarter.
  • Ashton Thomas Private Wealth sold 188 AtriCure shares in Q3 2024, an estimated $4.28K.
  • Ashton Thomas Private Wealth first reported a position in AtriCure in Q2 2024 and held it in 1 quarter.
  • Ashton Thomas Private Wealth's AtriCure position peaked at $4.28K in Q2 2024.
  • 201 funds tracked by Wall St. Rank held AtriCure as of Q3 2024.

Based on Ashton Thomas Private Wealth's 13F filing for Q3 2024, filed 5 Nov 2024.